The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial (316671)
ARTG Name
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
Product name
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
gemtuzumab ozogamicin
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information